DarioHealth, Glytec ink joint marketing deal
DarioHealth (NSDQ:DRIO) said today it inked a joint marketing agreement with Glytec through which DarioHealth’s smart glucose meter will be able to transmit information to Glytec’s Glucommander Outpatient software.
Israel-based DarioHealth said that blood glucose data from its Dario Blood Glucose Monitoring System will now be imported into the Glucommander Outpatient for use in conjunction with other clinical data to create personalized insulin dose recommendations.
Read the whole story on our sister site, Drug Delivery Business News
The post DarioHealth, Glytec ink joint marketing deal appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Diabetes Featured DarioHealth Corp Glytec Source Type: news
More News: Diabetes | Endocrinology | Insulin | Israel Health | Marketing | Medical Devices | Middle East Health